Stock Scorecard



Stock Summary for Avantor Inc (AVTR) - $11.73 as of 11/28/2025 8:46:34 PM EST

Total Score

6 out of 30

Safety Score

39 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for AVTR

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for AVTR

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for AVTR

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for AVTR

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for AVTR (39 out of 100)

Stock Price Rating (Max of 10) 5
Historical Stock Price Rating (Max of 10) 8
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 1
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 2
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for AVTR

Avantor Performance Materials acquires Puritan Products 11/4/2025 3:51:00 AM
Rosen Law Firm Urges Avantor, Inc. (NYSE: AVTR) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights 11/2/2025 11:35:00 AM
Avantor Reports Q3 2025 Results Amid Strategic Changes 10/31/2025 4:01:00 AM
Avantor Minimized Competition On Lab Biz, Investor Says 10/31/2025 4:01:00 AM
Stockholder Alert: Robbins LLP Informs Investors of the Avantor, Inc. Class Action Lawsuit 10/31/2025 4:01:00 AM
Avantor® Reports Third Quarter 2025 Results 10/31/2025 4:01:00 AM
Avantor Struggles With Soft Demand But Backs Long-Term Value Through Buyback 10/31/2025 4:01:00 AM
AVANTOR, INC. (NYSE: AVTR) INVESTOR ALERT Investors With Large Losses in Avantor, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights 10/31/2025 12:00:00 AM
Biotech Equipment Market to Approach $144B by 2030: Implications for Pharma R&D - BioPharm International 10/16/2025 4:36:00 PM
Avantor partners with BlueWhale Bio to advance CAR-T manufacturing By Investing.com - Investing.com Canada 10/16/2025 3:28:00 AM

Financial Details for AVTR

Company Overview

Ticker AVTR
Company Name Avantor Inc
Country USA
Description Avantor, Inc. is a leading global provider of mission-critical products and services serving the biopharmaceutical, healthcare, education, and advanced technology sectors. Based in Radnor, Pennsylvania, the company operates extensively across North America, Europe, Asia, the Middle East, and Africa, offering a diverse portfolio of high-quality materials and laboratory services that drive efficiency in scientific research and production. Avantor's commitment to innovation and sustainability, coupled with its strategic collaborations with customers, positions it as a key player in advancing the life sciences and advanced materials industries, ultimately enhancing healthcare outcomes and scientific breakthroughs.
Sector Name HEALTHCARE
Industry Name MEDICAL INSTRUMENTS & SUPPLIES
Most Recent Quarter 9/30/2025
Next Earnings Date 1/29/2026

Stock Price History

Last Day Price 11.73
Price 4 Years Ago 42.14
Last Day Price Updated 11/28/2025 8:46:34 PM EST
Last Day Volume 4,510,987
Average Daily Volume 11,645,203
52-Week High 23.32
52-Week Low 10.82
Last Price to 52 Week Low 8.41%

Valuation Measures

Trailing PE N/A
Industry PE 399.77
Sector PE 89.93
5-Year Average PE 21.07
Free Cash Flow Ratio 31.70
Industry Free Cash Flow Ratio 42.50
Sector Free Cash Flow Ratio 29.09
Current Ratio Most Recent Quarter 1.49
Total Cash Per Share 0.37
Book Value Per Share Most Recent Quarter 8.17
Price to Book Ratio 1.44
Industry Price to Book Ratio 3.55
Sector Price to Book Ratio 33.13
Price to Sales Ratio Twelve Trailing Months 1.22
Industry Price to Sales Ratio Twelve Trailing Months 45.76
Sector Price to Sales Ratio Twelve Trailing Months 16.04
Analyst Buy Ratings 5
Analyst Strong Buy Ratings 1

Share Statistics

Total Shares Outstanding 681,815,000
Market Capitalization 7,997,689,950
Institutional Ownership 102.25%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -34.20%
Annual Earnings Growth 121.58%
Reported EPS 12 Trailing Months -0.13
Reported EPS Past Year 0.69
Reported EPS Prior Year 1.00
Net Income Twelve Trailing Months -82,200,000
Net Income Past Year 711,500,000
Net Income Prior Year 321,100,000
Quarterly Revenue Growth YOY -5.30%
5-Year Revenue Growth 2.35%
Operating Margin Twelve Trailing Months 8.48%

Balance Sheet

Total Cash Most Recent Quarter 251,900,000
Total Cash Past Year 261,900,000
Total Cash Prior Year 262,900,000
Net Cash Position Most Recent Quarter -3,386,200,000
Net Cash Position Past Year -2,972,800,000
Long Term Debt Past Year 3,234,700,000
Long Term Debt Prior Year 5,276,700,000
Total Debt Most Recent Quarter 3,638,100,000
Equity to Debt Ratio Past Year 0.65
Equity to Debt Ratio Most Recent Quarter 0.60
Total Stockholder Equity Past Year 5,956,700,000
Total Stockholder Equity Prior Year 5,252,600,000
Total Stockholder Equity Most Recent Quarter 5,570,200,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 523,600,000
Free Cash Flow Per Share Twelve Trailing Months 0.77
Free Cash Flow Past Year 692,000,000
Free Cash Flow Prior Year 723,600,000

Options

Put/Call Ratio 0.57
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.45
MACD Signal -0.54
20-Day Bollinger Lower Band 10.40
20-Day Bollinger Middle Band 12.79
20-Day Bollinger Upper Band 15.19
Beta 0.93
RSI 46.94
50-Day SMA 15.21
150-Day SMA 20.04
200-Day SMA 21.95

System

Modified 11/28/2025 6:12:04 PM EST